PIPELINE

Clinical Trials

Dendreon currently has ongoing studies in advanced prostate cancer.

P10-3 (PROCEED)

  • A Registry of Sipuleucel-T in Men with Advanced Prostate Cancer (PROCEED) to Further Evaluate Safety and Survival Associated with Sipuleucel-T
  • To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.

P11-3 (STAMP)

  • A Randomized, Open-Label, Phase 2 Trial of Sipuleucel-T with Concurrent Versus Sequential Administration of Abiraterone Acetate Plus Prednisone in Men with Metastatic Castrate Resistant Prostate Cancer
  • To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.

P12-1 (PREDICT)

  • An Observational Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Metastatic Disease in Castrate-Resistant Prostate Cancer
  • To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.

P12-2 (STRIDE)

  • A Randomized, Open-Label, Phase 2 Trial Examining Combination Therapy with Sipuleucel-T and Enzalutamide in Men with Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate Cancer.
  • To learn more about the eligibility criteria and to find a clinical research facility nearest you, please click here or go to http://www.clinicaltrials.gov.

This list may not be fully up to date. For current status and more information on our ongoing clinical trials, please visit http://www.clinicaltrials.gov.